Colinz Laboratories P/E Ratio
Current P/E Ratio
3.6
Low Valuation
Very Low - Potentially undervalued or facing challenges
Colinz Laboratories (COLINZ) P/E ratio is 3.6 (Low), EPS (TTM) ₹2.04, current price ₹79.75 on BSE — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see Colinz Laboratories share price today.
Current Valuation Metrics
P/E Ratio
3.6
Current Price
₹79.75
EPS (TTM)
₹2.04
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
55.4
Sector Median
30.95
Sector Rank
#3 of 197
Sector Percentile
1.5%
COLINZ P/E Ratio — Valuation Signal & Historical Context
Colinz Laboratories P/E 3.6 — signal: Undervalued. Read COLINZ dividend payout details for the complete payout history and dividend yield track record.
- Stock appears undervalued with PE of 3.6, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.4
COLINZ vs Healthcare Peers — P/E Ratio Comparison
Colinz Laboratories P/E 3.6 vs Healthcare average 55.4, median 30.95 — range 2.86–706.0.
Sector Average
55.4
Sector Median
30.95
Lowest P/E
2.86
Highest P/E
706.0
Companies
197
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.29 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |
| Amwill Health Care | AMWILL | 7.6 | ₹87 | Low |